Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adaptor-associated protein kinase 1 (AAK1) is a serine/threonine protein kinase that regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2), facilitating cargo recognition and vesicle formation during receptor internalization. It plays an essential role in the trafficking and internalization of various membrane-bound receptors, endocytic accessory factor recruitment, and has been implicated in the regulation of the Notch signaling pathway. AAK1 is also involved in the entry and lifecycle of several RNA viruses, including hepatitis C, dengue, and Ebola, making it a promising antiviral drug target; inhibitors of AAK1 are being explored for their ability to disrupt viral entry and replication. Therapeutic targeting must account for its broad role in endocytosis and signaling to avoid off-target effects.
Inhibition of AAK1 kinase activity impairs clathrin-mediated endocytosis, thereby blocking intracellular trafficking and entry of multiple RNA viruses and, potentially, influencing receptor signaling
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adaptor-associated protein kinase 1 (AAK1).